Health TrialsbyHealthPanel

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

ConditionBrain Injuries
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorSherief Abd-Elsalam

About this trial

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children with traumatic brain injury: Moderate and Severe.

Disqualifiers

Underlying CNS disorders,

Trial design

Design model

Parallel

Treatments tested in this trial

  • Nucleo CMP Forte

    Drug

    Nucleo CMP Forte twice daily for 6 weeks

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Nucleo CMP forteExperimental treatment 1 intervention
Group B: Supportive treatmentNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Number of patients with improved glasgow coma score

The number of patients with improved glasgow coma score

Time frame
2 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sherief Abd-Elsalam

Lead sponsor

Tanta University

Sponsor institution

Source ClinicalTrials.gov
Apply now